Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Pain ; 25(6): 104466, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38218509

ABSTRACT

Chronic pain presents an enormous personal and economic burden and there is an urgent need for effective treatments. In a mouse model of chronic neuropathic pain, selective silencing of key neurons in spinal pain signalling networks with botulinum constructs resulted in a reduction of pain behaviours associated with the peripheral nerve. However, to establish clinical relevance it was important to know how long this silencing period lasted. Now, we show that neuronal silencing and the concomitant reduction of neuropathic mechanical and thermal hypersensitivity lasts for up to 120d following a single injection of botulinum construct. Crucially, we show that silencing and analgesia can then be reinstated with a second injection of the botulinum conjugate. Here we demonstrate that single doses of botulinum-toxin conjugates are a powerful new way of providing long-term neuronal silencing and pain relief. PERSPECTIVE: This research demonstrates that botulinum-toxin conjugates are a powerful new way of providing long-term neuronal silencing without toxicity following a single injection of the conjugate and have the potential for repeated dosing when silencing reverses.


Subject(s)
Disease Models, Animal , Neuralgia , Animals , Mice , Neuralgia/drug therapy , Male , Mice, Inbred C57BL , Chronic Pain/drug therapy , Botulinum Toxins, Type A/pharmacology , Botulinum Toxins, Type A/administration & dosage , Hyperalgesia/drug therapy , Botulinum Toxins/administration & dosage , Botulinum Toxins/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...